| Structure |
Chemical Name |
CAS |
MF |
 |
Azilsartan Impurity |
1675221-59-6 |
C25H22N2O5 |
 |
Apremilast Impurity QY |
|
|
 |
アジスロマイシンB |
307974-61-4 |
C38H72N2O11 |
 |
N-エチル-N-ニトロソ-2-プロパンアミン |
16339-04-1 |
C5H12N2O |
|
|
デクラジノシルアジスロマイシン |
|
|
 |
Methyl 3-aMino-2-((2'-carbaMoylbiphenyl-4-yl)MethylaMino)benzoate |
147404-75-9 |
C22H21N3O3 |
 |
Azilsartan iMpurity O |
2171316-29-1 |
C23H19N3O4 |
|
|
AzithroMycin IMpurity K |
|
|
 |
O-Desethyl Azilsartan |
1442400-68-1 |
C23H16N4O5 |
 |
Apremilast Impurity FA |
2077897-94-8 |
C21H22N2O7S |
|
|
Atracurium Impurity S |
|
|
|
|
Atracurium Impurity 29 |
|
|
|
|
Atracurium Impurity 32 |
|
|
 |
1449029-77-9 |
1449029-77-9 |
C29H26N4O7 |
|
|
Azilsartan Impurity 107 |
|
|
 |
レキシスロマイシン |
53066-26-5 |
C38H70N2O13 |
|
|
Azilsartan iMpurity G |
|
|
|
|
Atracurium Impurity F |
|
|
 |
Apremilast Impurity 15 |
2096492-41-8 |
C22H26N2O8S |
|
|
Atracurium Impurity O |
|
|
|
|
Atracurium Impurity 4 |
|
|
|
|
Atracurium Impurity P |
|
|
|
|
Atracurium Impurity U |
|
|
 |
Azilsartan Impurity 11 |
91526-16-8 |
C12H12O6S |
|
|
Atracurium Impurity G Complete Set |
|
|
![2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-,1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium benzenesulfonate](/CAS/GIF/1075727-06-8.gif) |
2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-,1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium benzenesulfonate |
1075727-06-8 |
C24H32NO6.C6H5O3S |
|
|
AzithroMycin iMpurity R |
|
|
|
|
AtracuriuM IMpurity H (Mixture of cis, trans(H1), cis, cis(H2)
tans, trans IsoMer) |
1248429-33-5 |
|
|
|
Atracurium Impurity B |
87046-74-0 |
|
|
|
Atracurium Impurity 2 |
|
|
 |
Atracurium Impurity 25 |
86682-55-5 |
C20H25NO5 |
|
|
Apremilast Impurity SJM |
|
|
 |
Atracurium Impurity 15 Iodide（Cisatracurium Besilate EP Impurity O Iodide） |
155913-31-8 |
C38H49NO11S |
|
|
Apremilast ImpurityTNN |
|
|
 |
trans N-Benzyl Paroxetine |
105813-14-7 |
C26H26FNO3 |
|
|
Lasmiditan Impurity 10 |
|
|
|
|
Nilotinib N-Oxide Impurity 3 |
|
|
|
|
Pemetrexed Impurity 51 |
|
|
|
|
6-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-7-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
|
 |
(S)-タムスロシン塩酸塩 |
106463-19-8 |
C20H28N2O5S.ClH |
 |
2,2'-Bisnalmefene |
176220-84-1 |
C42H48N2O6 |
 |
4-Desmethoxypropoxyl-4-chloro Rabeprazole |
168167-42-8 |
C14H12ClN3OS |
 |
AtracuriuM IMpurity D2 (cis-Quaternary Alcohol) |
1100676-16-1 |
C35H47NO10S |
|
|
AzithroMycin IMpurity O |
|
|
 |
AtracuriuM IMpurity V |
1075726-86-1 |
C25H34INO6 |
 |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |
![2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide](/CAS/20180601/GIF/1276524-56-1.gif) |
2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
1276524-56-1 |
C17H10D4F3N3O3S |
 |
1,1-ジフェニル-1-プロパノール |
5180-33-6 |
C15H16O |
 |
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
![(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20180601/GIF/96847-52-8.gif) |
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
![12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate](/CAS/20180703/GIF/176515-52-9.gif) |
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
 |
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
|
|
Ceftazidime Impurity D |
|
|
|
|
Ceftazidime Sulfoxide Impurity |
|
|
![N-メチル-2-[4-[(Z)-1-(4-ヒドロキシフェニル)-2-フェニル-1-ブテニル]フェノキシ]エタンアミン](/CAS/GIF/110025-28-0.gif) |
N-メチル-2-[4-[(Z)-1-(4-ヒドロキシフェニル)-2-フェニル-1-ブテニル]フェノキシ]エタンアミン |
110025-28-0 |
C25H27NO2 |
 |
Rebeprazole sulfone N-oxide |
924663-37-6 |
C18H21N3O5S |
 |
3,5-ジヨード-4-(3,5-ジヨード-4-ヒドロキシフェノキシ)ベンゼン酢酸 |
67-30-1 |
C14H8I4O4 |
 |
N-(スルホオキシ)-4-メトキシ-1H-インドール-3-アセトイミド酸O-(β-D-グルコピラノシルチオ) |
83327-21-3 |
C17H22N2O10S2 |
 |
4-methylsulfinylbenzoate |
33963-58-5 |
C8H8O3S |
|
|
Capecitabine Related Compound C |
|
|
 |
Glycopyrrolate Erythro Isomer |
201667-20-1 |
|
 |
5-クロロ-N-(4,5-ジヒドロ-1H-イミダゾール-2-イル)キノキサリン-6-アミン |
91147-46-5 |
C11H10ClN5 |
 |
(S)-(+)-3-HYDROXYTETRAHYDROFURAN |
79107-75-8 |
C4H8OS |
 |
4-Chlor-3-nitro-5-sulfobenzoesure |
130262-91-8 |
C7H4ClNO7S |
 |
4-(4-メチルピペラジン-1-イルメチル)安息香酸 |
106261-48-7 |
C13H18N2O2 |
 |
Α,Α-ジフェニル-4-ピペリジノメタノール塩酸塩 |
1798-50-1 |
C18H22ClNO |
 |
3-(2-amino-1-hydroxyethyl)benzene-1,2-diol |
73660-93-2 |
C8H11NO3 |
 |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile |
641571-12-2 |
C12H8F3N3 |
 |
3-メトキシ-1,3,5(10)-エストラトリエン-16α,17β-ジオール |
1474-53-9 |
C19H26O3 |
 |
7-Epi-10-oxo-docetaxel (Docetaxel Impurity D) |
162784-72-7 |
C43H51NO14 |
 |
(3-CHLORO-3-PHENYL-PROPYL)-DIMETHYL-AMINE HYDROCHLORIDE |
79130-51-1 |
C11H16ClN |
 |
(ジメチルアミノ)アセトアルデヒド ジメチル アセタール |
38711-20-5 |
C6H15NO2 |
 |
Dasatinib N-Oxide |
910297-52-8 |
C22H26ClN7O3S |
![[(R)-1-メチル-2-(6-アミノ-9H-プリン-9-イル)エトキシ]メチルホスホン酸ジエチル](/StructureFile/ChemBookStructure8/GIF/CB6190088.gif) |
[(R)-1-メチル-2-(6-アミノ-9H-プリン-9-イル)エトキシ]メチルホスホン酸ジエチル |
180587-75-1 |
C13H22N5O4P |
 |
P-TOLYL-PROPYNOIC ACID ETHYL ESTER |
52188-06-4 |
C12H12O2 |
 |
セルトラリン塩酸塩 RACEMIC MIXTURE (1:1 MIXTURE OF (1S, 4S) AND (1R, 4R)-4-(3,4-DICHLOROPHENYL)-N-METHYL-1,2,3,4-TETRAHYDRO-1-NAPHTHYLAMINE HYDROCHLORIDE) |
79617-89-3 |
C17H17Cl2N.HCl |
 |
2,4-ジメチルジフェニルスルフィド, IN ISOOCTANE (500ΜG/ML) |
16704-47-5 |
C14H14S |
![ジベンゾ[b,e]オキセピン-11(6H)-オン](/CAS/GIF/4504-87-4.gif) |
ジベンゾ[b,e]オキセピン-11(6H)-オン |
4504-87-4 |
C14H10O2 |
 |
N-ホルミル-1-(2-アミノ-1-(4-メトキシフェニル)エチル)シクロヘキサノール |
272788-07-5 |
C16H23NO3 |
|
|
Tofacitinib Impurity Y |
|
|
 |
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
|
|
Labetalol EP impurity G |
|
|
 |
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |
 |
CLOZAPINE-D3 |
1215691-72-7 |
C18H19ClN4 |
|
|
Bendamustine Impurity 25 |
|
|
|
|
Canagliflozin Impurity 25 |
|
|
 |
Edoxaban Impurity 41 |
1353893-25-0 |
C14H27N3O3 |
|
|
Istradefylline Impurity 5 |
|
|
|
|
Milrinone Impurity 10 |
|
|
 |
Olanzapine Impurity 3 |
|
C17H20N4S |
|
|
Ticagrelor Related Compound 54 |
|
|
|
|
Blonanserin Impurity N |
|
|
|
|
Brexpiprazole Impurity N |
|
|
|
|
Cefaclor Impurity 1 |
|
|
|
|
Cefminox Sodium impurity 4 |
|
|
|
|
Cefradine Impurity B |
|
|
|
|
Dapoxetine Impurity F |
|
|
|
|
Olaparib Impurity E |
|
|
 |
Cefathiamidine Impurity 6 |
28240-16-6 |
C12H13ClN2O6S |
![rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol)](/CAS/20211123/GIF/1882095-50-2.gif) |
rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol) |
1882095-50-2 |
C27H43N5O10S |